Boehringer Ingelheim Vetmedica Ltd has announced that Metacam is now available for use in pigs as an oral suspension.  Boehringer Ingelheim Vetmedica Ltd has announced that Metacam is now available for use in pigs as an oral suspension.  

Metacam, which contains the non-steroidal anti-inflammatory drug (NSAID) meloxicam, is indicated for the treatment of non-infectious locomotor disorders to reduce inflammation and signs of lameness. It is also licensed for the treatment of mastitis-metritis-agalactia (MMA) syndrome in sows, when used alongside appropriate antibiotic therapy. MMA is a multifactorial condition that can threaten the health of the sow and the lives of her piglets due to a marked decrease or complete cessation in milk production. 

Boehringer says treatment with Metacam15 mg/ml oral suspension helps control inflammation and pain associated with the condition, thereby helping to restore productivity and wellbeing in the sow and her offspring.

Metacam 15mg/ml oral suspension for pigs supplements the existing injectable formulation and has been introduced to its increase flexibility and ease of use, and to reduce the potential stress than can be caused when injecting newly-farrowed sows. The palatable suspension can be given mixed with a small quantity of feed or can be administered directly into the mouth.

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.